NCT04740268

Straberi Microneedling For Atrophic Acne

Clinical Trial Study for the Use of Straberi Microneedling Device to Treat Atrophic Acne Scarring

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Universal Skincare Institute · Academic / Other
• Sex: All
• Age: 21 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This pilot study will expand knowledge and application needling using the Straberi microneedling device for the improvement of Atrophic Acne Scarring

Detailed description

This pilot study will expand the knowledge and application of needling using the Straberi microneedling device and its safety and benefits for improving the appearance of atrophic acne scarring. The pilot aims to objectively measure skin quality using the Derma Scan, photographs, and provide objective data showing improvement by way of the Goodman and Barons quantitative scar scale.

Conditions

• Atrophic Acne Scar

Interventions

Type	Name	Description
DEVICE	Straberi	The patient's entire face will be treated with the Straberi microneedling devise. The following settings will be used as a treatment protocol. Needle length between .02- 1.55 mm

Timeline

• Start date: 2022-12-23
• Primary completion: 2023-06-30
• Completion: 2023-10-12
• First posted: 2021-02-05
• Last updated: 2023-12-06

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study